Memo Therapeutics AG

Memo Therapeutics AG

featured image of Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!

Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!

BIOT

📢 German CDMO Wacker Biotech opens €100m RNA manufacturing site, creating 100 jobs and expanding expertise in RNA active ingredients. 💪🌍

featured image of Swiss Antibody Specialist Secures CHF 45m Funding for Groundbreaking Research

Swiss Antibody Specialist Secures CHF 45m Funding for Groundbreaking Research

BIOT

💰 Swiss antibody specialist Memo Therapeutics AG secures CHF 45m in Series C financing, including CHF 20m from new investors. 🧪💉🌡️